Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition
about
sameAs
Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptorsDysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional studyClinical therapeutic strategies for early stage of diabetic kidney disease.Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.Bradykinin decreases podocyte permeability through ADAM17-dependent epidermal growth factor receptor activation and zonula occludens-1 rearrangementGenipin inhibits mitochondrial uncoupling protein 2 expression and ameliorates podocyte injury in diabetic mice.Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathy.Messenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathyTranscriptome analysis of human diabetic kidney diseaseThe renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations.Effect of Cordyceps sinensis and Tripterygium wilfordii polyglycosidium on podocytes in rats with diabetic nephropathy.Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy.Recent advances in diabetic nephropathyACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation.Early-onset diabetic E1-DN mice develop albuminuria and glomerular injury typical of diabetic nephropathy.Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus.Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats.Diet-Induced Podocyte Dysfunction in Drosophila and Mammals.Hyperglycemia and renal mass ablation synergistically augment albuminuria in the diabetic subtotally nephrectomized rat: implications for modeling diabetic nephropathyDiabetic nephropathy: the proteinuria hypothesis.Research into the glomerular podocyte--is it relevant to diabetic nephropathy?Effects of perindopril in hypertensive patients with or without type 2 diabetes mellitus, and with altered insulin sensitivity.Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study.Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetesEndothelial-podocyte crosstalk: the missing link between endothelial dysfunction and albuminuria in diabetes.Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathwayAdvanced glycation end-products reduce podocyte adhesion by activating the renin-angiotensin system and increasing integrin-linked kinase.Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.Inhibiting Amadori-modified albumin formation improves biomarkers of podocyte damage in diabetic rats.Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria.Taurine alleviates the progression of diabetic nephropathy in type 2 diabetic rat model.Which antihypertensive drugs are the most nephroprotective and why?Pathophysiology of the diabetic kidney.Functions of the podocyte proteins nephrin and Neph3 and the transcriptional regulation of their genes.Renin-angiotensin system within the diabetic podocyte.Role of protein kinase C in podocytes and development of glomerular damage in diabetic nephropathy.Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytesAn update: the role of Nephrin inside and outside the kidney.The role of novel biomarkers in predicting diabetic nephropathy: a review.Effects of insulin and high glucose on mobilization of slo1 BKCa channels in podocytes.
P2860
Q24305523-B503CC79-3200-4E4E-9900-B4824BA3F0ADQ28729900-E02922BE-29F0-4567-9F97-ECAB1BD06500Q30363683-5C273627-BC30-4ED9-A08A-663A9FDC9BF3Q33750632-6F59A667-67DD-441A-AD4C-A1971531AE47Q34128805-A20CA1DC-319F-4583-A72A-E8DFBF962A01Q34358426-6F589778-43F1-400B-8A32-5DA729483D3CQ34926825-8A549D7A-8D11-4AB4-AAB0-F4CF3591404EQ35011234-B85F80D8-1DDE-42F4-A5B6-A555D1D84F11Q35180096-85A803E9-8EAA-47C9-9837-547FFC774ED7Q35182095-A26A5982-B48D-4E2F-85AC-7CC381B2F5E8Q35187481-7D0C22FC-21A0-41C2-9DB0-3832FDFD71BEQ35203400-1AAF75A4-4A01-4C2D-B6FE-1FEC3AB521D4Q35520625-FB48325A-DDDD-4748-9AC3-A1CFC7DC4F8FQ35547522-3AD52F0E-268B-4DF7-A639-6A79E1CA81A9Q35591301-51D0FE80-2EFC-4191-86EF-4E01A032FC82Q35763771-99E26707-B324-43D6-BC86-6369CBEDA3FDQ35924532-A865239C-1664-4F2B-A516-2E1109F454AFQ35941157-74BFD3C4-692C-4FAF-B9DA-49F312CFF63EQ36058792-077FBD20-D975-48C2-B1EE-ECD89B3C17F0Q36061335-D36E1171-C573-4EF6-86D3-83702FF985EAQ36536737-65BCC650-F7A1-4CDB-A343-F6039F321EB0Q36956471-59F48D3A-36A6-4F79-BC0B-DB1CA2F90E8CQ37167598-899348E2-9035-4EB4-8A0B-870FE5671626Q37244688-C88B7B74-5A92-47D1-BDE3-F600FC4991CCQ37251105-47DE437D-0B7F-48DB-A2DE-72B1E38019AFQ37269951-0BD1E5C8-7626-4DBE-8656-6C3F1E97A820Q37313263-F5C52AE2-7CE2-4BD2-A759-0C37E1E707AFQ37317440-CFF229E8-256B-43A2-B2EF-9AC9BA4D1C22Q37319338-6B4D4758-1525-42C8-AF75-6E7605D82CFFQ37364926-8A3CFDD0-3C21-4759-8185-E8E98E77A571Q37636034-B050D660-3C55-4C14-9555-29C31240187BQ37803235-47A43CF9-29D1-44A7-B7E8-922C86A8DDD1Q38111707-CA4001C2-4BA6-407C-BF33-A925C2DB86C9Q38161936-8B5CB90A-B944-4508-B928-B4C4196374A3Q38262105-22CFCDD2-7E8A-4782-A564-1B8441D26354Q38270180-AF54B977-9C68-4FE8-86F0-71266E18D01AQ38332511-BBBD88DF-C37D-44B2-80F5-81F1432DF349Q38447905-4E99F02D-0FAC-48F0-97F0-0BD29D2A8AF8Q38598929-6C243328-02A3-406A-8220-24547B347A35Q39527086-C8026299-C744-4B04-A77B-669FC936E5B1
P2860
Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition
description
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im November 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: November 2002)
@en
vedecký článok (publikovaný 2002-11)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd in 2002-11)
@nl
наукова стаття, опублікована в листопаді 2002
@uk
مقالة علمية (نشرت في نوفمبر 2002)
@ar
name
Proteinuria and the expression ...... n converting enzyme inhibition
@ast
Proteinuria and the expression ...... n converting enzyme inhibition
@en
Proteinuria and the expression ...... n converting enzyme inhibition
@nl
type
label
Proteinuria and the expression ...... n converting enzyme inhibition
@ast
Proteinuria and the expression ...... n converting enzyme inhibition
@en
Proteinuria and the expression ...... n converting enzyme inhibition
@nl
prefLabel
Proteinuria and the expression ...... n converting enzyme inhibition
@ast
Proteinuria and the expression ...... n converting enzyme inhibition
@en
Proteinuria and the expression ...... n converting enzyme inhibition
@nl
P2093
P3181
P1433
P1476
Proteinuria and the expression ...... n converting enzyme inhibition
@en
P2093
D J Cordonnier
H Holthöfer
N M Thomson
R E Gilbert
R G Langham
P2888
P304
P3181
P356
10.1007/S00125-002-0946-Y
P407
P577
2002-11-01T00:00:00Z
P5875
P6179
1013509783